APO-GAIN LIQ 20MG/ML SOLUTION

Negara: Kanada

Bahasa: Inggris

Sumber: Health Canada

Bahan aktif:

MINOXIDIL

Tersedia dari:

APOTEX INC

Kode ATC:

D11AX01

INN (Nama Internasional):

MINOXIDIL, TOPICAL

Dosis:

20MG

Bentuk farmasi:

SOLUTION

Komposisi:

MINOXIDIL 20MG

Rute administrasi :

TOPICAL

Unit dalam paket:

60

Jenis Resep:

OTC

Area terapi:

MISC. SKIN AND MUCOUS MEMBRANE AGENTS

Ringkasan produk:

Active ingredient group (AIG) number: 0114429001; AHFS:

Status otorisasi:

MARKETED

Tanggal Otorisasi:

1992-12-31

Karakteristik produk

1
PRODUCT MONOGRAPH
APO-GAIN
MINOXIDIL TOPICAL SOLUTION USP
20 MG/ML (2% W/V)
HAIR REGROWTH TREATMENT
THIS PRODUCT IS FOR MEN ONLY
APOTEX INC.
150 SIGNET DRIVE
TORONTO ONTARIO
DATE OF REVISION:
M9L 1T9
January 06, 2020.
SUBMISSION CONTROL NO: 232446
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................ 3
SUMMARY PRODUCT INFORMATION
......................................................................................
3
INDICATIONS AND CLINICAL USE
............................................................................................
3
CONTRAINDICATIONS
.................................................................................................................
3
WARNINGS AND PRECAUTIONS
................................................................................................
4
ADVERSE REACTIONS
..................................................................................................................
5
DRUG INTERACTIONS
..................................................................................................................
8
OVERVIEW
......................................................................................................................................
8
DOSAGE AND ADMINISTRATION
..............................................................................................
9
OVERDOSAGE
..............................................................................................................................
12
ACTION AND CLINICAL PHARMACOLOGY
..........................................................................
13
DOSAGE FORM, COMPOSITION AND PACKAGING
............................................................. 15
PART II: SCIENTIFIC INFORMATION
..................................................................................
16
PHARMACEUTICAL INFORMATION
........................................................................................
16
CLINICAL TRIALS
............................